Literature DB >> 7342693

Adenosine antagonism, a less desirable characteristic of xanthine asthma drugs?

C G Persson, I Erjefält, J A Karlsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7342693     DOI: 10.1111/j.1600-0773.1981.tb00913.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


× No keyword cloud information.
  12 in total

1.  Evidence that the positive inotropic effects of the alkylxanthines are not due to adenosine receptor blockade.

Authors:  M G Collis; J R Keddie; S R Torr
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

Review 2.  Management of chronic obstructive pulmonary disease.

Authors:  S Kesten; A S Rebuck
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

3.  The role of adenosine in exercise hyperaemia of the gracilis muscle in anaesthetized cats.

Authors:  S M Poucher; C G Nowell; M G Collis
Journal:  J Physiol       Date:  1990-08       Impact factor: 5.182

Review 4.  Sustained release theophylline preparations. Practical recommendations for prescribing and therapeutic drug monitoring.

Authors:  A Glynn-Barnhart; M Hill; S J Szefler
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

5.  Protein binding of enprofylline.

Authors:  K Tegnér; O Borgå; I Svensson
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Pharmacokinetics of enprofylline in patients with impaired renal function after a single intravenous dose.

Authors:  E Lunell; O Borgå; R Larsson
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Maximally effective plasma concentrations of enprofylline and theophylline during constant infusion.

Authors:  L C Laursen; N Johannesson; I Søndergaard; B Weeke
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

8.  Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation.

Authors:  M J Finney; J A Karlsson; C G Persson
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

9.  Effects of probenecid on enprofylline kinetics in man.

Authors:  O Borgå; R Larsson; E Lunell
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Intravenous administration of enprofylline to asthmatic patients.

Authors:  L C Laursen; N Johannesson; P O Fagerström; B Weeke
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.